258 related articles for article (PubMed ID: 17432976)
1. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
Tanaka H; Ito T; Kyo T; Kimura A
Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
[TBL] [Abstract][Full Text] [Related]
2. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.
Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS
Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346
[TBL] [Abstract][Full Text] [Related]
3. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.
Tecchio C; Huber V; Scapini P; Calzetti F; Margotto D; Todeschini G; Pilla L; Martinelli G; Pizzolo G; Rivoltini L; Cassatella MA
Blood; 2004 May; 103(10):3837-44. PubMed ID: 14726404
[TBL] [Abstract][Full Text] [Related]
4. [Effects of interferon on the expressions of TRAIL and other apoptosis- inducing genes in peripheral blood mononuclear cells from polycythemia rubra vera].
Liu YF; Chen SM; Sun H
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):323-6. PubMed ID: 16875583
[TBL] [Abstract][Full Text] [Related]
5. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
[TBL] [Abstract][Full Text] [Related]
6. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia.
Ito K; Tanaka H; Ito T; Sultana TA; Kyo T; Imanaka F; Ohmoto Y; Kimura A
Eur J Haematol; 2004 Sep; 73(3):191-205. PubMed ID: 15287917
[TBL] [Abstract][Full Text] [Related]
7. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH
Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346
[TBL] [Abstract][Full Text] [Related]
10. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
[TBL] [Abstract][Full Text] [Related]
11. [Lipopolysaccharide (LPS) increases tumor necrosis factor-alpha related apoptosis induced-ligand (TRAIL) in macrophages killing HepG2 cells].
Zheng L; Yang YD; Lü GC; Ruan B; Sheng JF; Chen YG
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):689-91. PubMed ID: 16174461
[TBL] [Abstract][Full Text] [Related]
12. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
13. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
[TBL] [Abstract][Full Text] [Related]
14. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
15. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
[TBL] [Abstract][Full Text] [Related]
16. TRAIL receptors in the serum of patients with B-cell chronic lymphocytic leukemia.
Jablonska E; Kiersnowska-Rogowska B; Aleksandrowicz-Bukin M; Rogowski F; Sawicka-Powierza J
Neoplasma; 2008; 55(1):51-4. PubMed ID: 18190241
[TBL] [Abstract][Full Text] [Related]
17. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein that can be reactivated by matrix metalloproteinases.
Shin JN; Park SY; Cha JH; Park JY; Lee BR; Jung SA; Lee ST; Yun CW; Seol DW; Kim TH
Exp Cell Res; 2006 Nov; 312(19):3892-8. PubMed ID: 16996498
[TBL] [Abstract][Full Text] [Related]
18. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
Salehi E; Vodjgani M; Massoud A; Keyhani A; Rajab A; Shafaghi B; Gheflati Z; Aboufazeli T
Iran J Immunol; 2007 Dec; 4(4):197-205. PubMed ID: 18057577
[TBL] [Abstract][Full Text] [Related]
20. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
